BioMarin Pharmaceuticals BMRN Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) reported total assets of $8.59B in Q1 2026.
- How has BioMarin Pharmaceuticals's total assets changed year-over-year?
- BioMarin Pharmaceuticals's total assets increased by 20.2% year-over-year, from $7.15B to $8.59B.
- What is the long-term trend for BioMarin Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total assets has grown at a 5.4% compound annual growth rate (CAGR), from $5.85B to $7.59B.
- What does total assets mean?
- The sum of everything the company owns that has economic value.
- How do you interpret total assets?
- Growth in total assets generally signals business expansion, though it must be balanced against the growth of liabilities to assess net value creation.
- How does total assets compare across companies?
- Standard metric used across all industries to measure company size and asset base.